Advertisement
U.S. markets open in 2 hours 22 minutes
  • S&P Futures

    5,306.50
    -1.75 (-0.03%)
     
  • Dow Futures

    40,142.00
    -2.00 (-0.00%)
     
  • Nasdaq Futures

    18,496.25
    -7.50 (-0.04%)
     
  • Russell 2000 Futures

    2,136.60
    -1.80 (-0.08%)
     
  • Crude Oil

    82.23
    +0.88 (+1.08%)
     
  • Gold

    2,233.30
    +20.60 (+0.93%)
     
  • Silver

    24.80
    +0.05 (+0.19%)
     
  • EUR/USD

    1.0793
    -0.0036 (-0.33%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    12.99
    +0.21 (+1.64%)
     
  • GBP/USD

    1.2617
    -0.0021 (-0.17%)
     
  • USD/JPY

    151.3740
    +0.1280 (+0.08%)
     
  • Bitcoin USD

    70,674.77
    +604.62 (+0.86%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,954.82
    +22.84 (+0.29%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Should You Think About Buying Thermo Fisher Scientific Inc. (NYSE:TMO) Now?

Let's talk about the popular Thermo Fisher Scientific Inc. (NYSE:TMO). The company's shares saw a decent share price growth in the teens level on the NYSE over the last few months. With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Let’s examine Thermo Fisher Scientific’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

View our latest analysis for Thermo Fisher Scientific

What's the opportunity in Thermo Fisher Scientific?

According to my valuation model, Thermo Fisher Scientific seems to be fairly priced at around 12% below my intrinsic value, which means if you buy Thermo Fisher Scientific today, you’d be paying a fair price for it. And if you believe the company’s true value is $563.45, then there isn’t much room for the share price grow beyond what it’s currently trading. In addition to this, Thermo Fisher Scientific has a low beta, which suggests its share price is less volatile than the wider market.

Can we expect growth from Thermo Fisher Scientific?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Though in the case of Thermo Fisher Scientific, it is expected to deliver a relatively unexciting earnings growth of 6.9%, which doesn’t help build up its investment thesis. Growth doesn’t appear to be a main reason for a buy decision for the company, at least in the near term.

What this means for you:

Are you a shareholder? It seems like the market has already priced in TMO’s future outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?

Are you a potential investor? If you’ve been keeping an eye on TMO, now may not be the most optimal time to buy, given it is trading around its fair value. However, the positive outlook means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. Every company has risks, and we've spotted 1 warning sign for Thermo Fisher Scientific you should know about.

If you are no longer interested in Thermo Fisher Scientific, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Advertisement